DRIO

DarioHealth Corp

Add to Watchlist

Advanced Chart

0.651

-0.02(-2.978%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

0.6819

Open

0.6637

VWAP

0.66

Vol

178.59K

Mkt Cap

28.95M

Low

0.650

Amount

117.25K

EV/EBITDA(TTM)

Total Shares

29.92M

30.10M

EV/OCF(TTM)

P/S(TTM)

1.20

DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q2

FY2025Q3

FY2025Q4

6.91M

+10.39%

8.54M

+15.09%

9.84M

+29.39%

Estimates Revision

The market is revising Upward the revenue expectations for DarioHealth Corp. (DRIO) for FY2025, with the revenue forecasts being adjusted by 12.25% over the past three months. During the same period, the stock price has changed by -17.18%.

Revenue Estimates for FY2025

Revise Upward

+12.25%

In Past 3 Month

Stock Price

Go Down

-17.18%

In Past 3 Month

3 Analyst Rating

181.02% Upside

Wall Street analysts forecast DRIO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DRIO is 1.83 USD with a low forecast of 1.00 USD and a high forecast of 3.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

1 Hold

0 Sell

Moderate Buy

181.02% Upside

Current: 0.651

Low

1.00

Averages

1.83

High

3.00

181.02% Upside

Current: 0.651

Low

1.00

Averages

1.83

High

3.00

Litchfield Hills

Theodore O'Neill

Buy

initiated

2025-05-19

Reason

Litchfield Hills

Theodore O'Neill

Price Target

2025-05-19

initiated

Buy

Reason

Stifel

Buy

downgrade

2025-05-14

Reason

Stifel

Price Target

2025-05-14

downgrade

Buy

Reason

Stifel lowered the firm's price target on DarioHealth to $1.50 from $2 and keeps a Buy rating on the shares following a below Q1, reflecting transition of scope with large national health plan and modest impact from downstream tariff-related delays within their partner channel. The firm is lowering 2025 revenue estimate to reflect this dynamic. However, significant contract awards in the last several months should begin ramping in the second half of 2025 and into 2026. Management is still targeting free cash flow breakeven in Q1 2026. While possible, Stifel's estimates are less aggressive. It continues to estimate the company has sufficient cash/borrowing capacity to fund operations through achieving breakeven. While there are still several moving pieces impacting near-term growth, the firm is encouraged by management's ability to lower expenses and continues to sign meaningful new customer relationships.

Stifel

David Grossman

Strong Buy

Maintains

$3.5 → $2

2025-03-11

Reason

Stifel

David Grossman

Price Target

$3.5 → $2

2025-03-11

Maintains

Strong Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for DarioHealth Corp (DRIO.O) is -0.88, compared to its 5-year average forward P/E of -2.54. For a more detailed relative valuation and DCF analysis to assess DarioHealth Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-2.54

Current PE

-0.88

Overvalued PE

-0.84

Undervalued PE

-4.25

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-3.16

Current EV/EBITDA

-2.58

Overvalued EV/EBITDA

-1.23

Undervalued EV/EBITDA

-5.09

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

4.71

Current PS

0.82

Overvalued PS

8.77

Undervalued PS

0.65

Financials

Annual

Quarterly

FY2025Q1

YoY :

+17.26%

6.75M

Total Revenue

FY2025Q1

YoY :

-45.08%

-9.41M

Operating Profit

FY2025Q1

YoY :

+28.60%

-9.23M

Net Income after Tax

FY2025Q1

YoY :

-48.15%

-0.14

EPS - Diluted

FY2025Q1

YoY :

-49.08%

-6.70M

Free Cash Flow

FY2025Q1

YoY :

+36.10%

57.49

Gross Profit Margin - %

FY2025Q1

YoY :

-44.27%

-115.00

FCF Margin - %

FY2025Q1

YoY :

+9.67%

-136.66

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

4.5K

USD

Months

0-12

43.2K

USD

Months

Hedge Fund

Hedge Funds areSelling! The selling amount has increased 109.67% over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

0.0

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

0.0

Volume

Months

6-9

0.0

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

4.5K

USD

Months

0-12

43.2K

USD

Months

DRIO News & Events

Events Timeline

2025-06-26 (ET)

2025-06-26

08:37:02

DarioHealth and GreenKey Health partner in sleep apnea program

2025-05-14 (ET)

2025-05-14

06:36:51

DarioHealth reports Q1 EPS (14c), consensus (5c)

2025-04-21 (ET)

2025-04-21

08:33:29

DarioHealth CFO stepping down May 15th, Chen Franco-Yehuda to succeed

News

7.5

06-26Newsfilter

Dario and GreenKey Health Announce Strategic Commercial Agreement to Transform Chronic Condition Management and Sleep Health for Payers Nationwide

3.5

06-24Newsfilter

Dario Unveils Groundbreaking GLP-1 and AI-Personalization Digital Health Findings

3.5

05-08PRnewswire

Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations

People Also Watch

American Strategic Investment Co

Willamette Valley Vineyards Inc

Retractable Technologies Inc

LightInTheBox Holding Co Ltd

Calidi Biotherapeutics Inc

0.730

USD

-5.44%

FAQ

What is DarioHealth Corp (DRIO) stock price today?

The current price of DRIO is 0.6512 USD — it has decreased -2.98 % in the last trading day.

DRIO

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

DRIO News & Events

Events Timeline

News

People Also Watch

FAQ

What is DarioHealth Corp (DRIO) stock price today?

What is DarioHealth Corp (DRIO)'s business?

What is the price predicton of DRIO Stock?

What is DarioHealth Corp (DRIO)'s revenue for the last quarter?

What is DarioHealth Corp (DRIO)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for DarioHealth Corp (DRIO)'s fundamentals?

How many employees does DarioHealth Corp (DRIO). have?

What is DarioHealth Corp (DRIO) market cap?